Future studies will investigate whether DM-dependent peptide selection is required in the thymus for maturation of pathogenic CD4+ T cells and/or presentation of islet antigens for activation of autoreactive CD4+ T cells during the development of type 1 diabetes. This evidence concerns the gene CD4 and type 1 diabetes mellitus.